← FDA DRUG APPROVALS

FDA ANDA · ANDA206163

LEVOTHYROXINE SODIUM

Sponsor: PIRAMAL CRITICAL

APPLICATION
ANDA206163
TYPE
ANDA
ORIGINAL APPROVAL
2016-06-29
LATEST ACTION
2016-06-29
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued

Products

LEVOTHYROXINE SODIUMDiscontinued
LEVOTHYROXINE SODIUM 500MCG/VIAL · POWDER · INTRAVENOUS
LEVOTHYROXINE SODIUMDiscontinued
LEVOTHYROXINE SODIUM 100MCG/VIAL · POWDER · INTRAVENOUS

Approval history

2016-06-29UNKNOWN · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →